Primary endpoint results of the OMEGA Study: One-year clinical outcomes after implantation of a novel platinum chromium bare metal stent.

John C Wang,Didier Carrié,Monica Masotti,Andrejs Erglis,David Mego,Matthew W Watkins,Paul Underwood,Dominic J Allocco,Christian W Hamm

Cardiovascular Revascularization Medicine（2015）

引用 17|浏览26

暂无评分

摘要

•The OMEGA study evaluated a novel platinum chromium bare metal stent.•OMEGA enrolled 328 patients at 37 sites (US and Europe).•The primary endpoint of 9month target lesion failure was 11.5%.•One-year event rates were low including an ST rate of 0.6% at 12months.

查看译文

关键词

Bare metal stent,Platinum chromium

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要